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Introduction. Subcutaneous fat (ScF) and visceral fat (VF) measurements using CT scan are expensive and may imply signiﬁcant
radiation doses. Cross-sectional studies using CT scan showed that ScF and VF are signiﬁcantly correlated with abdominal fat
measured by DXA (AF-DXA). The association has not been studied after a weight loss. Objective. To determine (1) the associations
between AF-DXA and ScF and VF before and after weight loss and (2) the associations between their changes. Methods. 137
overweight/obese postmenopausal women were divided in two groups (1-caloric restriction or 2-caloric restriction + resistance
training). AF was assessed using DXA and CT scan. Results. Correlations between AF-DXA and ScF (before: r = 0.87, after;
r = 0.87; P<. 01) and, AF-DXA and VF (before: r = 0.61, after; r = 0.69; P<. 01) are not diﬀerent before and after the weight
loss. Correlations between delta AF-DXA and delta ScF (r = 0.72; P<. 01) or delta VF (r = 0.51; P<. 01) were found. Conclusion.
The use of AF-DXA as a surrogate for VF after weight loss is questionable, but may be interesting for ScF.
1.Introduction
Several health risks and metabolic disorders have been asso-
ciated with obesity such as lipid abnormalities, insulin resis-
tance, type 2 diabetes, cardiovascular diseases, orthopedics
complications, and certain forms of cancer [1–3]. Indeed,
several studies showed that an excessive accumulation of fat
in the abdominal region (AF) is strongly related to health
hazards [4], including several component of the metabolic
syndrome (MetS) such as insulin resistance, dyslipidemia,
and elevated blood pressure as well as with proinﬂammatory
and prothrombotic states [1, 4–11].
In women, the menopause-induced loss of estrogens
leads to an accumulation of AF rather than peripheral
adiposity [12–14]. The AF is composed of two main diﬀerent
layers, subcutaneous fat (ScF) and visceral fat (VF) [15].
Currently, the excessive accumulation of VF is considered
as the most deleterious fat depot for the metabolic proﬁle
and health [8, 12, 16–23], but excess of ScF is also linked
to metabolism abnormalities mostly glucose metabolism
disturbances [23–29] and elevated C-reactive protein levels
in women [30]. Nonetheless, the implication of ScF in MetS
remains unclear and has been reported to be less important
than VF [1, 15, 23, 24, 27].2 Journal of Obesity
Studies showed that overweight and obese subjects
engaged in diet- or exercise-induced weight loss programs
can signiﬁcantly reduce AF, ScF, and VF, which have also
been correlated with improvements in the metabolic proﬁle
[31–34]. Interestingly, metabolic improvements have been
reported even with weight losses as small as 5% to 10%
[31–35]. Studies also reported that individuals participating
in a structured exercise program can lose signiﬁcant AF
amount (particularly VF), even in the absence of body
weight loss [32–34, 36]. Because of the metabolic and
health risks associated with VF, it is important to promote
weight loss strategies that speciﬁcally target decreases in
VF.
The accurate measurement of AF, ScF and VF can be
done using computed tomography (CT scan) or magnetic
resonance imaging (MRI). In fact, the measurement of VF
with these methods is expensive and limited due to the
accessibility to the equipment. The use of CT scan has also
raised some concerns regarding the exposition of subjects to
radiation doses [37–39]. Hence, developing highly reliable
surrogate measures of VF and ScF using simpler, less
expensive and more widely available techniques would be
highly useful [40]. Considering these criteria, AF measured
by DXA (AF-DXA) may be an interesting alternative. A
few cross-sectional studies reported that AF by DXA is
signiﬁcantly and strongly correlated with AF measured by
CT scans (AF-CT) (r ranging from 0.86 to 0.98; P ≤ .001)
[38, 41, 42]. It remains to be determined, however, if changes
in AF-DXA can correctly predict changes in ScF and VF after
a weight loss intervention.
The main objectives of this study were (1) to determine
the association between AF measured by DXA and ScF,
VF and AF measured by CT scan after weight loss in
obese postmenopausal women, (2) to examine associations
between changes in these variables after weight loss. Finally
a second-level objective is to evaluate if AF-DXA could be
a good surrogate of single-slice CT scan assessment of ScF
and VF after a weight loss and to detect changes induced by
weight loss in these compartments.
2.Materials/SubjectsandMethods
2.1. Subjects. The MONET project (Montreal Ottawa New
Emerging Team in Obesity) is designed to investigate, using
a randomized controlled design, the impact of resistance
training during weight loss (6 months) on various param-
eters including body composition as previously reported [43,
44]. Brieﬂy 137 overweight/obese postmenopausal women
were randomly assigned in a 2:1 fashion to a 6-month
caloric restriction diet (CR) alone or a CR diet + resistance
training program (RT). During the 6-month weight loss
phase, 30 women out of 137 dropped out of the study,
yielding a dropout rate of 21.9%. Thus, 107 women (71
CR and 36 RT + CR) completed the 6-month weight loss
phase [45]. Baseline characteristics of dropouts were not
diﬀerent from those of subjects who completed the study,
except for lean body mass which was lower in dropouts
(40.6 ± 3.8v e r s u s4 2 .8 ± 6.6, P<. 05) (results not
showed). This study was approved by the Universit´ ed e
Montr´ eal Ethics Committee. After receiving a complete
verbal and written description of the experimental proto-
col and potential risks, each participant provided signed
consent.
Womenwereeligibletoparticipateiftheyweresedentary,
overweight, or obese and did not present signiﬁcant health
complications. Complete inclusion and exclusion criteria
have previously been reported [43]. For the purpose of this
study, we ﬁrst selected a sample composed of 131 obese
post-menopausal women (57.6 ± 4.8 yrs) for whom we had
all baseline anthropometric, DXA, and CT scan data. We
use this sample to perform correlations at baseline between
AF by DXA and ScF and VF by CT scan. Secondly, to
assess diﬀerences between groups at baseline and to examine
changes following the intervention within each group, we
selectedfromthepreviousmentionedsampleallwomenwho
completed the weight loss program and in whom we had
all 6-month anthropometric, DXA, and CT scan data (total
n = 92). These women were distributed as follows: CR group
(n = 64) and CR +RT (n = 28).
2.2.CaloricRestriction Interventionwithor withoutResistance
Training Intervention. All study participants entered a 6-
month weight loss program aimed at reducing body weight
by 10% using a standardized diet with 55%, 30%, and 15%
of energy intake from carbohydrates, total fat, and protein
according to the American Heart Association [46].
A subset also participated to a 6-month resistance
training program. Details about these interventions have
been previously reported [43].
2.3. Anthropometry. Body weight was measured to the
nearest 0.1kg on a calibrated scale (Balance Industrielle
Montr´ eal, Montr´ eal, Qu´ ebec, Canada) and subject’s height
wasobtainedwithastandardstadiometer(PerspectiveEnter-
prises, Portage, MI, USA). Percentage of fat (%F) and total
fat were measured using dual energy X-ray absorptiometry
(DXA) (General Electric Lunar Prodigy, Madison, WI, USA;
software version 6.10.019), as previously described [31, 47].
The amount of abdominal fat (AF-DXA) is automatically
generated in the DXA body composition report obtained
by a whole-body assessment, as well as other regions (arms
and legs). During the procedure, subjects were asked to
wear only a standard hospital gown while in the supine
position. Calibration was performed daily with a standard
phantom. In our laboratory, the intraclass coeﬃcient cor-
relation for test-retest for AT and lean body mass was 0.99
(n = 18).
2.4. Computed Tomography. A CT scanner (GE LightSpeed
16, General Electric Medical Systems, Milwaukee, WY, USA)
was used to measure the visceral fat (VF) and the abdominal
subcutaneous tissue (ScF) area. The sum of ScF and VF
was used to calculate the abdominal fat by CT (AF-CT).
Subjects were examined in the supine position with both
arms stretched above their head. The position of the scan
was established at the L4-L5 vertebral disc using a scout
image of the body [31, 47]. We quantiﬁed VF by delineatingJournal of Obesity 3
Table 1: Descriptive characteristics.
Baseline n = 131 6 months n = 92 Changes n = 92
Age (years) 57.6 ± 4.8
Weight (kg) 83.2 ± 12.67 8 .8 ± 12.8∗ −5.2 ± 5.0
BMI (kg/m2)3 2 .4 ± 4.33 0 .4 ± 4.2∗ −2.0 ± 1.9
WC (cm) 95.8 ± 9.29 1 .0 ± 9.3∗ −5.0 ± 4.0
AF-DXA 18.2 ± 5.01 5 .6 ± 4.7∗ −2.6 ±2.5
AF-CT 650.8 ± 143.9 578.0 ± 148.6∗ −71.3 ± 65.6
ScF 466.0 ± 112.9 417.1 ± 114.8∗ −49.7 ± 45.1
VF 184.8 ± 55.2 160.9 ± 57.1∗ −21.6 ± 29.9
Mean ±SD.
∗Signiﬁcant diﬀerence within group between 0-month and 6-month measures, P ≤ .05.
BMI: Body Mass Index (kg/m2); WC:Waist Circumference (cm); AF-DXA:Abdominal Fat by DXA (kg); AF-CT:Abdominal Fat by CT scan (cm2);
ScF:Abdominal Subcutaneous Fat by CT scan (cm2); VF:Visceral Fat by CT scan (cm2).
the intraabdominal cavity at the internal most aspect of
the abdominal and oblique muscle walls surrounding the
cavity and the posterior aspect of the vertebral body. The
abdominalScFareawasquantiﬁedbyhighlightingfatlocated
between the skin and the external most aspect of the
abdominal muscle wall. The cross-sectional areas of fat were
highlighted and computed using an attenuation range of
−190 to −30 Hounsﬁeld Units (HU).
2.5. Statistical Analyses. Results are presented as the mean
± standard deviation (± SD). First, unpaired t-tests were
performed to compare groups, while ANOVA for repeated
measures were used to examine changes following the
intervention within each group and between groups (time ×
groupinteraction).Sincenodiﬀerencewasobservedbetween
groups for AF, ScF, and VF before and after interventions
(results not shown), data were pooled for statistical analyses
purposes. Finally, Pearson correlations were used to assess
the association between AF-DXA (by DXA) and ScF, VF,
and AF-CT (by CT scan). To perform Pearson correlation
coeﬃcients we considered all the women for whom we
had complete data for AF-DXA, ScF, VF and AF-CT. These
statistical analyses were performed using Statistical Package
for the Social Sciences (SPSS) version 15.0 (SPSS Inc.,
Chicago, IL, USA). Finally, we computed Z scores from our
correlation coeﬃcients to compare the slopes from pre- and
postintervention correlations. The level of signiﬁcance was
set at P ≤ .05.
3. Results
Descriptive characteristics are presented in Table 1.A sp r e -
viously reported, signiﬁcant diﬀerences were found between
baseline and postinterventions values [43]. Correlations
between AF-DXA, AF-CT, ScF, VF and WC before and after
weight loss were all statistically signiﬁcant (Tables 2 and
3;a l lP-values <. 01) and equivalent before and after the
intervention. Pearson’s correlations were also performed to
assess association between changes in AF-DXA, AF-CT, ScF,
VF, and WC (Table 4). Signiﬁcant correlations were also
Table 2: Pearson’s correlations between AF-DXA, AF-CT, ScF, VF,
and WC before weight loss interventions.
AF-DXA AF-CT ScF VF WC
AF-DXA 1
AF-CT 0.92∗ 1
ScF 0.87∗ 0.94∗ 1
VF 0.61∗ 0.69∗ 0.39∗ 1
WC 0.86∗ 0.84∗ 0.73∗ 0.70∗ 1
∗P ≤ .01 by Pearson’s correlation coeﬃcient.
AF-DXA: Abdominal Fat by DXA (kg); AF-CT:Abdominal Fat by CT
(SAT+VAT) (cm2); ScF:Abdominal Subcutaneous Fat by CT scan (cm2);
VF:Visceral Fat by CT scan (cm2); WC:Waist Circumference (cm).
Table 3: Pearson’s correlations between AF-DXA, AF-CT, ScF, VF,
and WC after weight loss interventions.
AF-DXA AF-CT ScF VF WC
AF-DXA 1
AF-CT 0.92∗ 1
ScF 0.86∗ 0.94∗ 1
VF 0.67∗ 0.72∗ 0.43∗ 1
WC 0.89∗ 0.87∗ 0.79∗ 0.69∗ 1
∗P ≤ .01 by Pearson’s correlation coeﬃcient.
AF-DXA: Abdominal Fat by DXA (kg); AF-CT: Abdominal Fat by CT
(SAT+VAT) (cm2); ScF: Abdominal Subcutaneous Fat by CT scan (cm2);
VF: Visceral Fat by CT scan (cm2); WC: Waist Circumference (cm).
obtained between (1) delta AF-DXA and delta ScF (r =
0.720; P<. 01), (2) delta AF-DXA and delta VF (r = 0.506;
P<. 01),and(3)deltaAF-DXAanddeltaAF-CT(r = 0.722;
P<. 01).
4. Discussion
The direct measurements of ScF and VF using multiple slices
by CT scan or using MRI are currently considered as gold
standard methods [29, 48]. However, these techniques are
expensive and not easily accessible. Furthermore, because4 Journal of Obesity
Table 4: Pearson’s correlations between changes in AF-DXA, AF-
CT, ScF, VF, and WC.
Delta
AF-DXA
Delta
AF-CT Delta ScF Delta VF Delta
WC
Delta
AF-DXA 1
Delta AF-CT 0.74∗ 1
Delta ScF 0.74∗ 0.92∗ 1
Delta VF 0.51∗ 0.81∗ 0.51∗ 1
Delta WC 0.58∗ 0.57∗ 0.52∗ 0.47∗ 1
∗P ≤ .01 by Pearson’s correlation coeﬃcient.
AF-DXA: Abdominal Fat by DXA (kg); AF-CT: Abdominal Fat by CT
(SAT+VAT) (cm2); ScF: Abdominal Subcutaneous Fat by CT scan (cm2);
VF: Visceral Fat by CT scan (cm2); delta AF-DXA: (AF-DXA6month–A F -
DXAbaseline); delta AF-CT: (AAT-CT6month–A A T - C T baseline); delta ScF:
(SAT6month–S A T baseline); delta VF: (VAT6month–V A T baseline); delta WC:
(WC6month–W C baseline).
CT scans expose subjects to radiation doses (ranging from
1.5mSv to 10mSv; with an average of 6mSv for a spine
assessment), they might not be recommended for repeated
measurements [38, 39]. For the purpose of the present study,
onlyasinglesliceatL4-L5wasacquired,whichcorresponded
to a dose of 0.012mSv. Considering the lower cost of use,
the shorter time of data acquisition and the lower ionizing
radiation doses of DXA (about 0.0013mSv for a whole-body
assessment) [37–39], it could be an interesting alternative to
assess changes in VF and ScF after weight loss interventions.
The present study showed that correlations obtained
between AF by DXA and AF-CT subcomponents before and
after weight loss ranged from moderate to good [15]a n d
were all signiﬁcant and are similar before and after weight
loss. Our results are in agreement with those of Snijder et al.
(2002)obtainedinastudyconductedinblackandwhitemen
and women aged between 70 and 79 years [49]. However,
results from other studies do not agree with ours [50, 51].
The latter studies showed abdominal fat measures by DXA
to be strongly correlated with VF measured by CT scan
or MRI (r between 0.83 and 0.90). Discrepancies between
our results and others are most likely due to diﬀerences
in populations studied. Indeed, in the present study, our
population was composed of obese postmenopausal women
as opposed to studies done in leaner men and women [50]
or men only [51]. Hence, our results suggest that it is more
diﬃculttopredictchangesinVFandScFusingDXAinobese
postmenopausalwomen.Thisexplainsthelowestcorrelation
between changes in AF-DXA and changes in VF in the
present study.
Parallel to our observations pre- and post intervention,
Clasey et al. also reported that DXA-derived AF is not a
better predictor of VF by CT scan than WC [50]. In our
study, AF-DXA accounted for only 45% of the variance of
VF after weight loss, and only 26% of the variance of changes
in this compartment as compared to 79% post intervention
and 34% of changes for WC. Then, in our opinion, these
relationships are too low to justify the use of a simple
measure of abdominal fat using DXA to assess changes in
the amount of visceral fat after weight loss. Thus, it seems
clinically more relevant to pursue using WC to estimate the
amount of VF after weight loss.
Interestingly, we also observed better correlations for ScF
with AF-DXA than for VF with AF-DXA, both before and
after weight loss. Indeed, the simple measure of AF-DXA
accounted for 74% of the variance of ScF after weight loss,
and for 76% of the variance of its changes. These results
suggest that DXA may be an interesting surrogate to CT scan
to estimate amount of ScF after weight loss and its changes,
depending on the precision required.
Nonetheless, other authors have developed equations
using anthropometric and/or DXA measures to estimate
VF accumulations in order to downplay the limitations
associated with the use of indirect measures of body fat
distribution [16, 38, 41, 42, 49–55]. For example, Garaulet
et al. (2006) developed a predictive equation of VF using 3
anthropometric variables (triceps skinfold, sagittal diameter
and coronal diameter). The authors reported a signiﬁcant
but moderate correlation with VF measured by CT scan
(r = 0.68; P< . 0001) [52]. In another study conducted
in 71 overweight and obese subjects (27 men and 44 women,
aged between 16 and 70 years), Bertin et al. (2000) developed
an equation strongly correlated with VF measured by CT
scan (r = 0.86; P<. 0001) [16]. Their equations must
however be used with caution since, to our knowledge, they
had never been validated in another population including
weight-reduced obese individuals.
In conclusions, cross-sectional analyses revealed good to
very good correlations between AF-DXA and ScF or AF-CT
before and after weight loss. On the other hand, changes in
AF-DXA were only moderately correlated to changes in VF.
In the light of our results, the use of CT scan remains the best
approach to precisely quantify the eﬀectof weightlossonVF.
However, DXA may be an interesting surrogate to estimate
the amount and changes in total abdominal fat or ScF before
and after a weight loss intervention in obese postmenopausal
women.
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